Back
Sarepta Therapeutics Vs. Live Oak Bancshares Industry Stock Comparison
Buy
55
SRPT
Sarepta Therapeutics
Last Price:
134.94
Seasonality Move:
14.17%
Sell
50
LOB
Live Oak Bancshares
Last Price:
35.46
Seasonality Move:
11.71%
Buy
55
Sarepta Therapeutics (SRPT)
is a Buy
Is Sarepta Therapeutics a Buy, Sell or Hold?
- The current Sarepta Therapeutics [SRPT] share price is $135.04. The Score for SRPT is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- SRPT is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Live Oak Bancshares (LOB)
is a Sell
Is Live Oak Bancshares a Buy, Sell or Hold?
- The current Live Oak Bancshares [LOB] share price is $35.45. The Score for LOB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
- LOB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $135.04
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
LOB Stock Price Chart
What is Live Oak Bancshares's stock price today?
-
The Live Oak Bancshares share price today is $35.45
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and LOB is experiencing slight buying pressure.
SRPT Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.15 | Buy |
| Relative Strength Index (14 RSI): | 68.89 | Buy |
| Chaikin Money Flow: | 478346 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (119.27 - 130.17) | Buy |
| Bollinger Bands (100): | (106.55 - 132.21) | Buy |
LOB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.28 | Sell |
| Relative Strength Index (14 RSI): | 44.55 | Sell |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (34.68 - 39.82) | Sell |
| Bollinger Bands (100): | (36.84 - 42.56) | Sell |
SRPT Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 130.2 | Buy |
| 20-day SMA: | 124.29 | Buy |
| 50-day SMA: | 125.73 | Buy |
| 200-day SMA: | 112.31 | Buy |
| 8-day EMA: | 130.01 | Buy |
| 20-day EMA: | 126.71 | Buy |
| 50-day EMA: | 124.46 | Buy |
| 200-day EMA: | 116.88 | Buy |
LOB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 34.04 | Buy |
| 20-day SMA: | 36.56 | Sell |
| 50-day SMA: | 38.44 | Sell |
| 200-day SMA: | 35.87 | Sell |
| 8-day EMA: | 35.02 | Buy |
| 20-day EMA: | 36.26 | Sell |
| 50-day EMA: | 37.7 | Sell |
| 200-day EMA: | 36.18 | Sell |
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.85 per share, an increase next quarter of $1.52 per share, an increase this year of $5.62 per share, and an increase next year of $6.11 per share.
Live Oak Bancshares Earnings Growth & LOB Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.13 per share, an increase this year of $0.41 per share, and an increase next year of $0.77 per share.
Sarepta Therapeutics Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Live Oak Bancshares Technical Analysis
| Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | May 2 | May 3 | May 6 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 23 | 24 | 25 | 26 | 29 | 30 | 01 | 02 | 03 | 06 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||